The antiobesity drug orlistat [`Xenical'; Roche] has been granted priority review status

Source: Inpharma, Volume 1, Number 1294, 2001 , pp. 22-22(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Orlistat, therapeutic use; Regulatory-process; Obesity, treatment; Type-2-diabetes-mellitus

Language: English

Document Type: Short communication

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$37.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A